Medtronic Board appoints Lidia Fonseca as a new director

DUBLIN, June 27, 2022 /PRNewswire/ — Medtronic plc (NYSE: MDT) as we speak introduced that its Board of Administrators appointed Lidia Fonseca, Government Vice President, Chief Digital and Know-how Officer at Pfizer, to the Board as an impartial director, efficient June 27, 2022. Ms. Fonseca will serve on the Compensation Committee and Science and Know-how Committee of the Board.

“We’re thrilled to welcome Lidia to Medtronic’s Board of Administrators,” stated Geoff Martha, Medtronic chairman and chief govt officer. “She has a formidable historical past of creating digital healthcare options that ship highly effective insights to enhance sufferers’ lives. Her in depth information and experience will present the Board with an vital dimension and a tremendously useful perspective as we drive towards our daring ambition to change into the worldwide chief in healthcare expertise.”

Ms. Fonseca has greater than 30 years of expertise in healthcare innovation. In her present function, she is chargeable for creating and implementing an enterprise-wide digital technique, main all digital, knowledge and expertise options throughout the corporate. She can also be chargeable for Pfizer Studying and Improvement and Enterprise Course of Excellence.

Ms. Fonseca additionally spearheads a number of revolutionary packages and initiatives, together with people who digitize drug discovery and growth; enhance well being outcomes and affected person experiences by digital well being, medicines, and diagnostics; advance operational processes by automation and robotics; and ship highly effective insights with superior analytics and synthetic intelligence (AI) for higher decision-making.

Most lately, she led Pfizer’s digital crew as the corporate made crucial efforts to assist speed up the event of a COVID-19 vaccine in lower than a 12 months. She additionally led the efforts to create Pfizer’s Superior Analytics Platform that mixes knowledge and instruments from Pfizer and its exterior companions to mannequin scientific and medical selections, patterns, and insights.

Previous to her present function, from 2014 to 2018, Ms. Fonseca was the Senior Vice President and CIO at Quest Diagnostics, the world’s main supplier of diagnostic info companies, the place she was chargeable for expertise, informatics, and digital options. Previous to that she served because the Senior Vice President and Chief Info Officer at Labcorp from 2008 to 2013.

All through her profession, Ms. Fonseca has acquired a number of awards and accolades, together with being named on the 2022 Forbes CIO Subsequent Checklist recognizing the highest 50 tech leaders who’re redefining the CIO function and driving game-changing innovation. She was acknowledged as one of many 50 Most Highly effective Latinas in 2020 and 2021 by the Affiliation of Latino Professionals for America, in addition to a 2020 Healthcare Influencer and 2019 Healthcare Transformer by Medical, Advertising and marketing & Media. She has acquired the Forbes CIO Innovation Award in 2017 and at the moment serves on the U.S.-Japan Enterprise Council.

About Medtronic
Daring pondering. Bolder actions. We’re Medtronic. Medtronic plc, headquartered in Dublin, Eire, is the main world healthcare expertise firm that boldly assaults essentially the most difficult well being issues going through humanity by looking for and discovering options. Our Mission — to alleviate ache, restore well being, and prolong life — unites a world crew of 95,000+ passionate individuals throughout 150 international locations. Our applied sciences and therapies deal with 70 well being circumstances and embrace cardiac gadgets, surgical robotics, insulin pumps, surgical instruments, affected person monitoring methods, and extra. Powered by our various information, insatiable curiosity, and need to assist all those that want it, we ship revolutionary applied sciences that rework the lives of two individuals each second, each hour, on daily basis. Anticipate extra from us as we empower insight-driven care, experiences that put individuals first, and higher outcomes for our world. In all the pieces we do, we’re engineering the extraordinary. For extra info on Medtronic (NYSE: MDT), go to www.Medtronic.com and observe @Medtronic on Twitter and LinkedIn.

Any forward-looking statements are topic to dangers and uncertainties akin to these described in Medtronic’s periodic experiences on file with the Securities and Alternate Fee. Precise outcomes could differ materially from anticipated outcomes.